Pin Pharma

US-based, preclinical-stage biopharma, developing a broad-base immunomodulatory cancer therapy

placeNew York City, New York, United States calendar_todayFounded 2011 groups1 employees language pinpharma.com

Innovation

5 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 839 times.

YearFilings
20121
20131
20142
20153
20163
20171
20182
20192
20202
20211

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon